MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.

MLA

Xue, Chengyuan, et al. “MYCN Promotes Neuroblastoma Malignancy by Establishing a Regulatory Circuit with Transcription Factor AP4.” Oncotarget, vol. 7, no. 34, Aug. 2016, pp. 54937–51. EBSCOhost, https://doi.org/10.18632/oncotarget.10709.

APA

Xue, C., Yu, D. M. T., Gherardi, S., Koach, J., Milazzo, G., Gamble, L., Liu, B., Valli, E., Russell, A. J., London, W. B., Liu, T., Cheung, B. B., Marshall, G. M., Perini, G., Haber, M., & Norris, M. D. (2016). MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4. Oncotarget, 7(34), 54937–54951. https://doi.org/10.18632/oncotarget.10709

Chicago

Xue, Chengyuan, Denise M T Yu, Samuele Gherardi, Jessica Koach, Giorgio Milazzo, Laura Gamble, Bing Liu, et al. 2016. “MYCN Promotes Neuroblastoma Malignancy by Establishing a Regulatory Circuit with Transcription Factor AP4.” Oncotarget 7 (34): 54937–51. doi:10.18632/oncotarget.10709.